Lidocaine Bp B. Braun Melsungen Ag (Lidocaine Hydrochloride Monohydrate)

Lidocaine works by binding to voltage‑gated sodium channels on neuronal membranes, stabilising the membrane and preventing the influx of sodium ions. This blocks the initiation and propagation of action potentials, thereby inhibiting nerve impulse transmission and producing a reversible loss of sensation in the treated area.

The dose of Lidocaine Bp B. Braun Melsungen Ag is determined by the prescribing clinician based on the specific procedure, patient weight, site of injection and desired depth of anesthesia. Only a qualified health professional should calculate and administer the appropriate amount.

Safety data for lidocaine in pregnancy and lactation are limited. The product is classified as having an unknown pregnancy category. Use should be considered only when the potential benefit justifies any possible risk to the fetus or infant, and it should be prescribed by a healthcare professional.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any cold‑chain requirements) and assist with import documentation.

Lidocaine is an amide‑type local anesthetic with a rapid onset (1–3 minutes) and intermediate duration (30–120 minutes). Compared with agents such as bupivacaine, it has a shorter duration but a lower risk of cardiotoxicity at therapeutic doses. Its versatility across intradermal, intramuscular and intravenous routes makes it a common choice for many minor procedures.

Lidocaine Bp B. Braun Melsungen Ag should be stored at room temperature, below 25 °C, in its original packaging. Protect the product from direct sunlight, moisture and extreme temperature fluctuations to maintain sterility and potency.

The product is administered by a qualified healthcare professional via intradermal, intramuscular or intravenous injection, depending on the clinical indication. Proper aseptic technique and accurate dosing are essential to achieve effective anesthesia while minimizing the risk of systemic toxicity.

Serious risks include systemic toxicity manifesting as central nervous system symptoms (seizures, confusion), cardiovascular effects (arrhythmias, hypotension, cardiac arrest), and rare allergic reactions such as anaphylaxis. Prompt recognition and supportive management are critical if these events occur.

Patients with a known hypersensitivity to lidocaine, other amide‑type local anesthetics, or any component of the formulation should avoid its use. Caution is also advised for individuals with severe heart block, significant hepatic impairment, or those taking interacting medications that may increase lidocaine plasma levels.